Grantham, Mayo, Van Otterloo & Co (GMO)
AMGN icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Amgen AMGN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,642
Closed -$1.52M – 633
2025
Q4 		$1.52M Hold
4,642
– – ﹤0.01% 434
2025
Q3 		$1.31M Buy
4,642
+397
+9% +$115K ﹤0.01% 426
2025
Q2 		$1.19M Buy
4,245
+481
+13% +$136K ﹤0.01% 447
2025
Q1 		$1.17M Sell
3,764
-673
-15% -$199K ﹤0.01% 435
2024
Q4 		$1.16M Buy
4,437
+928
+26% +$275K ﹤0.01% 432
2024
Q3 		$1.13M Buy
+3,509
New +$1.15M ﹤0.01% 429
2020
Q4 		– Sell
-43,879
Closed -$11.2M – 801
2020
Q3 		$11.2M Sell
43,879
-2,700
-6% -$669K 0.08% 145
2020
Q2 		$11M Sell
46,579
-17,952
-28% -$4.1M 0.08% 143
2020
Q1 		$13.1M Buy
64,531
+1,131
+2% +$247K 0.11% 122
2019
Q4 		$15.3M Sell
63,400
-13,200
-17% -$2.91M 0.1% 145
2019
Q3 		$14.8M Sell
76,600
-55,400
-42% -$10.6M 0.1% 138
2019
Q2 		$24.3M Sell
132,000
-2,800
-2% -$501K 0.17% 95
2019
Q1 		$25.6M Sell
134,800
-7,800
-5% -$1.49M 0.18% 78
2018
Q4 		$27.8M Buy
142,600
+800
+0.6% +$156K 0.22% 76
2018
Q3 		$29.4M Buy
141,800
+132,500
+1,425% +$26.1M 0.2% 79
2018
Q2 		$1.72M Buy
9,300
+2,400
+35% +$425K 0.01% 323
2018
Q1 		$1.18M Buy
6,900
+4,900
+245% +$899K 0.01% 367
2017
Q4 		$348K Sell
2,000
-200
-9% -$35.4K ﹤0.01% 498
2017
Q3 		$410K Hold
2,200
– – ﹤0.01% 433
2017
Q2 		$379K Buy
2,200
+200
+10% +$32.5K ﹤0.01% 434
2017
Q1 		$328K Sell
2,000
-499
-20% -$82.9K ﹤0.01% 429
2016
Q4 		$365K Buy
2,499
+100
+4% +$15.1K ﹤0.01% 433
2016
Q3 		$400K Sell
2,399
-400
-14% -$67.6K ﹤0.01% 413
2016
Q2 		$426K Sell
2,799
-151,216
-98% -$23.5M ﹤0.01% 487
2016
Q1 		$23.1M Sell
154,015
-201,848
-57% -$30M 0.09% 175
2015
Q4 		$57.8M Sell
355,863
-223,563
-39% -$35.1M 0.21% 93
2015
Q3 		$80.1M Sell
579,426
-49,534
-8% -$7.81M 0.28% 73
2015
Q2 		$96.6M Buy
628,960
+129,113
+26% +$20.7M 0.31% 69
2015
Q1 		$79.9M Sell
499,847
-526,304
-51% -$82.9M 0.24% 72
2014
Q4 		$163M Sell
1,026,151
-965,869
-48% -$151M 0.44% 47
2014
Q3 		$280M Sell
1,992,020
-1,268,900
-39% -$166M 0.74% 32
2014
Q2 		$386M Sell
3,260,920
-29,329
-0.9% -$3.4M 1.05% 24
2014
Q1 		$406M Buy
3,290,249
+167,503
+5% +$20.3M 1.06% 24
2013
Q4 		$356M Buy
3,122,746
+453,895
+17% +$51.6M 0.87% 27
2013
Q3 		$299M Buy
2,668,851
+602,464
+29% +$65.3M 0.79% 30
2013
Q2 		$204M Buy
+2,066,387
New +$214M 0.53% 35

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s AMGN Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Amgen (AMGN) in Q1 2026, closing a stake of 4,642 shares — an estimated $1.52M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMGN in Q2 2013 and held it in 36 quarters. The position peaked at $406M in Q1 2014. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,642 Amgen shares in Q1 2026, an estimated $1.52M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Amgen in Q2 2013 and held it in 36 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Amgen position peaked at $406M in Q1 2014.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.